Gordion Bioscience

Gordion Bioscience appears to be a legitimate seed-stage biotech startup using machine learning for cancer target identification, but this submission is riddled with severe red flags and obvious falsehoods. Claims such as 'most people have used my product' for a 2023 B2B biotech company, a target audience of 'everyone', and an illogical 'all time marketcap' of 2,500,000 for a private startup strongly indicate a fake or troll submission. Due to the blatantly false evidence of traction and extremely poor response quality, the project receives a negative score despite the underlying technology's theoretical utility.